Clinical trial
Riociguat (BAY 63-2521), a Stimulator of Soluble Guanylate Cyclase (sGC) - Migraine Induction in People With Migraine.
NCT05750446 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Riociguat (BAY 63-2521), a Stimulator of Soluble Guanylate Cyclase (sGC) - Migraine Induction in People With Migraine.
- Lead sponsor
- Danish Headache Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2023
- Completion date
- February 1, 2024
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.